Engraftment of human iPSC derived astrocytes into the forebrain of adult and neonatal wild type mice

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N95019Q00277 and the solicitation is issued as a request for quotation (RFQ).
This acquisition is for a commercial item and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.
THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institutes of Health (NIH) intends to negotiate and award a purchase order without providing for full and open competition (Including brand-name) to PsychoGenics (PGI Holding Corporation), at 215 College Road, Paramus, NJ 07652.
This acquisition is conducted as non-competitive for a commercial service and is conducted under the authority of the FAR Part 13 - Simplified Acquisition Procedures, and FAR 13.106-1(b) - Soliciting from a single source. The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted that produced no other sources capable of providing this Government requirement.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2019-03, effective July 12, 2019.
(iv) The associated NAICS code is 541380 and the small business size standard is $15M.
DESCRIPTION:
(v) The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) requires engraftment of human iPSC derived astrocytes into the forebrain of adult and neonatal wild type mice, in accordance with the attached Statement of Work.
(vi) The period of performance is 24 weeks, including receipt of all deliverables. The 24-week period of performance will begin when the contractor receives the cells from NCATS. The Contractor will receive the samples within 30 days of order.
(vii) The anticipated award date is August 20, 2019.
See the attached Request for Quotation for complete details and information..